伊立替康
顺铂
医学
依托泊苷
内科学
肺癌
化疗
肿瘤科
喜树碱
中期分析
癌症
随机对照试验
结直肠癌
生物
生物化学
作者
Kazumasa Noda,Yutaka Nishiwaki,Masaaki Kawahara,Shunichi Negoro,Takahiko Sugiura,Akira Yokoyama,Masahiro Fukuoka,Kiyoshi Mori,Koshiro Watanabe,Tomohide Tamura,Seiichiro Yamamoto,Nagahiro Saijo
摘要
Irinotecan hydrochloride, a topoisomerase I inhibitor, is effective against small-cell lung cancer. In a phase 2 study of irinotecan plus cisplatin in patients with extensive small-cell lung cancer, there was a high response rate and a promising median survival time.
科研通智能强力驱动
Strongly Powered by AbleSci AI
薰硝壤
不配.
彭于彦祖
pcr163
Leonardi
shinysparrow
Henry
加菲丰丰
苏书白
starofjlu
马大翔
从容芮
互助遵法尚德
五十一笑声
Miller
Singularity
quhayley
25号底片
科研文献搬运工
浅尝离白
皖公网安备34019202002308
